Pfizer says acquiring biotech firm Medivation for $14 billion
Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday.
Aug 22, 2016, 17:41 PM IST
Pfizer-Allergan $160 bn deal: Interesting facts and outcomes
Let's take a look at some of the interesting facts from the record USD 160 billion deal.
Nov 23, 2015, 23:22 PM IST